{"id":66867,"date":"2026-05-05T09:24:18","date_gmt":"2026-05-05T03:54:18","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=66867"},"modified":"2026-05-05T09:24:19","modified_gmt":"2026-05-05T03:54:19","slug":"alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/","title":{"rendered":"Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy"},"content":{"rendered":"<iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/CE_-rKoujHs?si=dqc0xYnJXyjUh0DT\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n\n<p class=\"wp-block-paragraph\">Alcohol septal ablation (ASA) is an established percutaneous intervention for symptomatic hypertrophic obstructive cardiomyopathy (HOCM) refractory to medical therapy. Since its introduction in the mid-1990s, it has evolved through refinements in myocardial contrast echocardiography and target vessel selection. The following sections highlight the foundational, registry-based, and state-of-the-art literature.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Foundational Research<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The conceptual origin of inducing a localized septal infarction to relieve left ventricular outflow tract (LVOT) obstruction was first published by <strong>Ulrich Sigwart<\/strong> in 1995.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/7616800\/\" type=\"link\" id=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/7616800\/\"><strong>Sigwart, U. (1995).<\/strong> Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. <em>The Lancet<\/em>, <em>346<\/em>(8969), 211\u2013214.<\/a>\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Significance:<\/strong> This landmark paper described the first three successful cases of percutaneous alcohol injection into the first septal perforator, demonstrating an immediate reduction in the LVOT gradient and providing a minimally invasive alternative to surgical myectomy.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Key Registries and Meta-Analyses<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Long-term safety and efficacy data are primarily derived from large multinational registries and systematic reviews comparing ASA to the surgical &#8220;gold standard.&#8221;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26746632\/\" type=\"link\" id=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26746632\/\"><strong>Veselka et al. (2016).<\/strong> Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: Results from the <strong>Euro-ASA registry<\/strong>. <em>European Heart Journal<\/em>, <em>37<\/em>(19), 1517\u20131523.<\/a>\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Significance:<\/strong> The largest multinational ASA registry (1,275 patients) reported a 30-day mortality of <strong>1%<\/strong> and a 10-year survival rate of <strong>77%<\/strong>. It established that residual LVOT gradient at follow-up is a strong predictor of long-term prognosis.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li class=\"\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26454847\/\" type=\"link\" id=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26454847\/\"><strong>Liebregts et al. (2015).<\/strong> A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. <em>JACC: Heart Failure<\/em>, <em>3<\/em>(11), 896\u2013905.<\/a>\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Significance:<\/strong> This study found that while long-term mortality and sudden cardiac death (SCD) rates were similar between ASA and surgical myectomy, ASA was associated with a significantly higher risk of <strong>permanent pacemaker implantation (10% vs. 4.4%)<\/strong> and a five-fold higher rate of <strong>reintervention (7.7% vs. 1.6%)<\/strong>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Current State-of-the-Art &amp; Guidelines<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Modern management emphasizes shared decision-making and the role of multidisciplinary &#8220;Heart Teams&#8221; in comprehensive HCM centers.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Clinical Guidelines<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38718139\/\" type=\"link\" id=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38718139\/\"><strong>Ommen et al. (2024).<\/strong> 2024 AHA\/ACC Guideline for the Management of Hypertrophic Cardiomyopathy. <em>Circulation<\/em><\/a>.\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>Significance:<\/strong> These guidelines recommend ASA as a <strong>Class 1<\/strong> strategy for symptomatic patients with resting or provoked gradients \u2265 50 mmHg. While myectomy is often preferred in younger patients or those with complex mitral valve anatomy, ASA is highly recommended for older adults or those with significant comorbidities.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Recent Comparative Developments<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li class=\"\"><strong>ASA vs. Myosin Inhibitors:<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41590843\/\" type=\"link\" id=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41590843\/\">Recent research<\/a> has compared ASA with novel pharmacotherapies like <strong>mavacamten<\/strong>. Both therapies achieve comparable reductions in afterload and improvements in diastolic filling pressures, though mavacamten may show a more pronounced reduction in left atrial volume index over time.<\/li>\n\n\n\n<li class=\"\"><strong>ASA vs. Radiofrequency Ablation (PESA):<\/strong> A <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40379240\/\" type=\"link\" id=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40379240\/\">comparative study<\/a> noted that while ASA provides superior reduction in LVOT gradients and septal thickness, percutaneous endocardial septal radiofrequency ablation (PESA) is significantly more effective at avoiding bundle branch blocks and conduction disturbances.<\/li>\n<\/ul>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n","protected":false},"excerpt":{"rendered":"<p>Alcohol septal ablation (ASA) is an established percutaneous intervention for symptomatic hypertrophic obstructive cardiomyopathy (HOCM) refractory to medical therapy. Since its introduction in the mid-1990s, it has evolved through refinements in myocardial contrast echocardiography and target vessel selection. The following sections highlight the foundational, registry-based, and state-of-the-art literature. Foundational Research The conceptual origin of inducing [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":66868,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-66867","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"Alcohol septal ablation (ASA) is an established percutaneous intervention for symptomatic hypertrophic obstructive cardiomyopathy (HOCM) refractory to medical therapy. Since its introduction in the mid-1990s, it has evolved through refinements in myocardial contrast echocardiography and target vessel selection. The following sections highlight the foundational, registry-based, and state-of-the-art literature. Foundational Research The conceptual origin of inducing [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-05T03:54:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-05T03:54:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Alcohol-Septal-Ablation-for-Hypertrophic-Obstructive-Cardiomyopathy.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy\",\"datePublished\":\"2026-05-05T03:54:18+00:00\",\"dateModified\":\"2026-05-05T03:54:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\\\/\"},\"wordCount\":439,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Alcohol-Septal-Ablation-for-Hypertrophic-Obstructive-Cardiomyopathy.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\\\/\",\"name\":\"Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Alcohol-Septal-Ablation-for-Hypertrophic-Obstructive-Cardiomyopathy.jpg\",\"datePublished\":\"2026-05-05T03:54:18+00:00\",\"dateModified\":\"2026-05-05T03:54:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Alcohol-Septal-Ablation-for-Hypertrophic-Obstructive-Cardiomyopathy.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Alcohol-Septal-Ablation-for-Hypertrophic-Obstructive-Cardiomyopathy.jpg\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/","og_locale":"en_US","og_type":"article","og_title":"Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy - All About Cardiovascular System and Disorders","og_description":"Alcohol septal ablation (ASA) is an established percutaneous intervention for symptomatic hypertrophic obstructive cardiomyopathy (HOCM) refractory to medical therapy. Since its introduction in the mid-1990s, it has evolved through refinements in myocardial contrast echocardiography and target vessel selection. The following sections highlight the foundational, registry-based, and state-of-the-art literature. Foundational Research The conceptual origin of inducing [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-05-05T03:54:18+00:00","article_modified_time":"2026-05-05T03:54:19+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Alcohol-Septal-Ablation-for-Hypertrophic-Obstructive-Cardiomyopathy.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy","datePublished":"2026-05-05T03:54:18+00:00","dateModified":"2026-05-05T03:54:19+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/"},"wordCount":439,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Alcohol-Septal-Ablation-for-Hypertrophic-Obstructive-Cardiomyopathy.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/","url":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/","name":"Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Alcohol-Septal-Ablation-for-Hypertrophic-Obstructive-Cardiomyopathy.jpg","datePublished":"2026-05-05T03:54:18+00:00","dateModified":"2026-05-05T03:54:19+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Alcohol-Septal-Ablation-for-Hypertrophic-Obstructive-Cardiomyopathy.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/05\/Alcohol-Septal-Ablation-for-Hypertrophic-Obstructive-Cardiomyopathy.jpg","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/alcohol-septal-ablation-for-hypertrophic-obstructive-cardiomyopathy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=66867"}],"version-history":[{"count":5,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66867\/revisions"}],"predecessor-version":[{"id":66873,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/66867\/revisions\/66873"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/66868"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=66867"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=66867"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=66867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}